The Food and Drug Administration (FDA) has released a vast amount of medical device data to its openFDA platform.
The openFDA initiative originated with an order from the White House calling for federal agencies to make government information more accessible to the public.
Since its launch, openFDA has added to a growing list of APIs, with endpoints related to drugs, devices and food.
The agency hopes the new information will "spur innovation and advance scientific research," according to information posted on its website.
OpenFDA’s API expands the previous openFDA resources about medical device-related adverse events and recalls by incorporating information from the total medical device product life cycle, including current data on device classification, registrations of device companies and establishments, and the companies’ listings of over 100,000 devices. There also is more information on device approvals and approval supplements, recalls and adverse event reports. The information has been available on public databases, but is now easier for developers to access and use.
The information doesn’t contain anything that potentially could be used to identify individuals or reveal confidential commercial information.